These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 26535869)

  • 21. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L; Marzo M; Andrisani G; Felice C; Pugliese D; Mocci G; Nardone O; De Vitis I; Papa A; Rapaccini G; Forni F; Armuzzi A
    Dig Liver Dis; 2014 Nov; 46(11):974-9. PubMed ID: 25096964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.
    Mooiweer E; Fidder HH; Siersema PD; Laheij RJ; Oldenburg B
    Inflamm Bowel Dis; 2014 Feb; 20(2):307-14. PubMed ID: 24374878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Calprotectin levels in patients with idiopathic inflammatory bowel disease comparison of two commercial tests].
    Malícková K; Janatková I; Bortlík M; Komárek V; Lukás M
    Epidemiol Mikrobiol Imunol; 2008 Nov; 57(4):147-53. PubMed ID: 19069028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of endoscopic disease activity in ulcerative colitis by two different assays for fecal calprotectin.
    Kristensen V; Klepp P; Cvancarova M; Røseth A; Skar V; Moum B
    J Crohns Colitis; 2015 Feb; 9(2):164-9. PubMed ID: 25518057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.
    Costa F; Mumolo MG; Ceccarelli L; Bellini M; Romano MR; Sterpi C; Ricchiuti A; Marchi S; Bottai M
    Gut; 2005 Mar; 54(3):364-8. PubMed ID: 15710984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Head-to-head comparison of three stool calprotectin tests for home use.
    Haisma SM; Galaurchi A; Almahwzi S; Adekanmi Balogun JA; Muller Kobold AC; van Rheenen PF
    PLoS One; 2019; 14(4):e0214751. PubMed ID: 30998692
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid fecal calprotectin correlates with clinical and endoscopic severity of inflammatory bowel diseases.
    Tursi A; Elisei W; Giorgetti G; Picchio M; Brandimarte G
    Scand J Gastroenterol; 2013 Nov; 48(11):1359-60. PubMed ID: 23971760
    [No Abstract]   [Full Text] [Related]  

  • 28. Can calprotectin predict relapse risk in inflammatory bowel disease?
    D'Incà R; Dal Pont E; Di Leo V; Benazzato L; Martinato M; Lamboglia F; Oliva L; Sturniolo GC
    Am J Gastroenterol; 2008 Aug; 103(8):2007-14. PubMed ID: 18802997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal calprotectin and the clinical activity index are both useful to monitor medical treatment in patients with ulcerative colitis.
    Burri E; Beglinger C; von Felten S; Lehmann FS
    Dig Dis Sci; 2015 Feb; 60(2):485-91. PubMed ID: 25344905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease.
    Daniluk U; Daniluk J; Krasnodebska M; Lotowska JM; Sobaniec-Lotowska ME; Lebensztejn DM
    Adv Med Sci; 2019 Mar; 64(1):9-14. PubMed ID: 30237086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fecal calprotectin as a biomarker of inflammatory lesions of the small bowel seen by videocapsule endoscopy.
    Egea-Valenzuela J; Alberca-de-Las-Parras F; Carballo-Álvarez F
    Rev Esp Enferm Dig; 2015 Apr; 107(4):211-4. PubMed ID: 25824919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fecal calprotectin levels predict the clinical course in patients with new onset of ulcerative colitis.
    Lasson A; Simrén M; Stotzer PO; Isaksson S; Ohman L; Strid H
    Inflamm Bowel Dis; 2013 Mar; 19(3):576-81. PubMed ID: 23377170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical value of fecal calprotectin in determining disease activity of ulcerative colitis.
    Xiang JY; Ouyang Q; Li GD; Xiao NP
    World J Gastroenterol; 2008 Jan; 14(1):53-7. PubMed ID: 18176961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.
    Rosenfeld G; Greenup AJ; Round A; Takach O; Halparin L; Saadeddin A; Ho JK; Lee T; Enns R; Bressler B
    World J Gastroenterol; 2016 Sep; 22(36):8211-8. PubMed ID: 27688663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease.
    Palone F; Vitali R; Cucchiara S; Pierdomenico M; Negroni A; Aloi M; Nuti F; Felice C; Armuzzi A; Stronati L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1448-57. PubMed ID: 24983978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fecal Human Neutrophil Peptide Levels Correlate with Intestinal Inflammation in Ulcerative Colitis.
    Kanmura S; Hamamoto H; Morinaga Y; Oda K; Fujita T; Arima S; Nasu Y; Sasaki F; Hashimoto S; Taguchi H; Setoyama H; Ido A
    Digestion; 2016; 93(4):300-8. PubMed ID: 27220673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fecal calprotectin more accurately reflects endoscopic activity of ulcerative colitis than the Lichtiger Index, C-reactive protein, platelets, hemoglobin, and blood leukocytes.
    Schoepfer AM; Beglinger C; Straumann A; Safroneeva E; Romero Y; Armstrong D; Schmidt C; Trummler M; Pittet V; Vavricka SR
    Inflamm Bowel Dis; 2013 Feb; 19(2):332-41. PubMed ID: 23328771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis.
    Annaházi A; Molnár T; Farkas K; Rosztóczy A; Izbéki F; Gecse K; Inczefi O; Nagy F; Földesi I; Szűcs M; Dabek M; Ferrier L; Theodorou V; Bueno L; Wittmann T; Róka R
    Inflamm Bowel Dis; 2013 Feb; 19(2):316-20. PubMed ID: 22550024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
    Kwapisz L; Mosli M; Chande N; Yan B; Beaton M; Micsko J; Mennill PW; Barnett W; Bax K; Ponich T; Howard J; Tirolese A; Lannigan R; Gregor J
    Saudi J Gastroenterol; 2015; 21(6):360-6. PubMed ID: 26655130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal calprotectin complements routine laboratory investigations in diagnosing childhood inflammatory bowel disease.
    Quail MA; Russell RK; Van Limbergen JE; Rogers P; Drummond HE; Wilson DC; Gillett PM
    Inflamm Bowel Dis; 2009 May; 15(5):756-9. PubMed ID: 19107785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.